[Analysis of Microbial Community Characteristics and Function Prediction of MBBR with Magnetic Biocarriers at Low Temperature].

In order to clarify effect of magnetic biocarriers on the performance of MBBR at low temperatures, the microbial diversity, community structure, functional characteristics, and nitrogen metabolism of biofilm in the reaction system were investigated. The results indicated that MBBR with magnetic biocarriers had a better pollutant removal efficiency, with the average removal rates of NH4+-N and TN being 16.2% and 12.1% higher than those in the control group (commercial biocarriers), respectively. Illumina high-throughput sequencing analysis showed that higher diversity and richness of the bacterial community was established in the biofilm of magnetic biocarriers. There were obvious differences in microbial community structure of biofilm between the two biocarrier duos to bacterial magnetic susceptibility. The relative abundances of nitrifying bacteria (e.g., Nitrosomonas and Nitrospira) and denitrifying bacteria (e.g., Sphaerotilus and Zoogloea) were increased in the magnetic biocarriers. Functional prediction analysis with PICRUSt2 showed that the microorganism of magnetic biocarriers had a better total gene function expression level, which was significantly more increased than commercial biocarriers in gene-representing signal transduction mechanisms and intracellular trafficking, secretion, and vesicular transport. Furthermore, most of the abundances of nitrogen metabolism genes were raised in the biofilm of magnetic biocarriers (e.g., genes amo and hao, were responsible for nitrification, and genes nap and nor, which were responsible for denitrification). Magnetic biocarriers increased biofilm potential for denitrification at low temperatures. Our results explained the difference in performance between the two reactors from microbiology and provided the theoretical basis for magnetic biocarrier-enhanced performances of MBBR at low temperatures.

Pediatric drug safety signal detection of non-chemotherapy drug-induced neutropenia and agranulocytosis using electronic healthcare records.

Objectives: This study aimed to develop a procedure to explore the adverse drug reaction signals of drug-induced neutropenia (DIN) or drug-induced agranulocytosis (DIA) in children using an electronic health records (EHRs) database. Methods: A two-stage design was presented. First, the suspected drugs to induce DIN or DIA were selected. Second, the associations were evaluated by a retrospective cohort study. Results: Ten and five drugs were potentially identified to be associated with DIN and DIA, respectively. Finally, five (oseltamivir, chlorpheniramine, vancomycin, meropenem, and ganciclovir) and two (chlorpheniramine, and vancomycin) drugs were found to be associated with DIN and DIA, respectively. Of these, the association between oseltamivir and neutropenia (P = 9.83 × 10-9; OR, 2.10; 95% CI, 1.62-2.69) was considered as a new signal for both adults and children. Chlorpheniramine-induced neutropenia (P = 3.01 × 10-8; OR, 1.59; 95% CI, 1.35-1.87) and agranulocytosis (P = 3.16 × 10-7; OR, 3.76; 95% CI, 2.25-6.26) were considered as new signals in children. Other drugs associated with DIN or DIA were confirmed by previous studies. Conclusion: A method to detect signals for DIN and DIA has been described. Several pediatric drugs were found to be associated with DIN or DIA.